As published by the Epi4K consortium in 2016, among 531 individuals with a variety of unresolved epileptic encephalopathy, targeted sequencing identified six infants with CACNA1A pathogenic variants (including an affected sibling), which were de novo in 3/5 families (21). This evidence concerns the gene CACNA1A and Epileptic encephalopathy.